These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

971 related items for PubMed ID: 26314519

  • 1. Practice patterns and postoperative complications before and after US Food and Drug Administration safety communication on power morcellation.
    Harris JA, Swenson CW, Uppal S, Kamdar N, Mahnert N, As-Sanie S, Morgan DM.
    Am J Obstet Gynecol; 2016 Jan; 214(1):98.e1-98.e13. PubMed ID: 26314519
    [Abstract] [Full Text] [Related]

  • 2. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
    Multinu F, Casarin J, Hanson KT, Angioni S, Mariani A, Habermann EB, Laughlin-Tommaso SK.
    JAMA Surg; 2018 Jun 20; 153(6):e180141. PubMed ID: 29641835
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Change in Surgical Practice for Women With Leiomyomas After the U.S. Food and Drug Administration Morcellator Safety Communication.
    Clark NM, Schembri M, Jacoby VL.
    Obstet Gynecol; 2017 Nov 20; 130(5):1057-1063. PubMed ID: 29016511
    [Abstract] [Full Text] [Related]

  • 5. Trends in Mode of Hysterectomy After the U.S. Food and Drug Administration Power Morcellation Advisory.
    Ottarsdottir H, Cohen SL, Cox M, Vitonis A, Einarsson JI.
    Obstet Gynecol; 2017 Jun 20; 129(6):1014-1021. PubMed ID: 28486371
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Are perioperative bundles associated with reduced postoperative morbidity in women undergoing benign hysterectomy? Retrospective cohort analysis of 16,286 cases in Michigan.
    Harris JA, Sammarco AG, Swenson CW, Uppal S, Kamdar N, Campbell D, Evilsizer S, DeLancey JO, Morgan DM.
    Am J Obstet Gynecol; 2017 May 20; 216(5):502.e1-502.e11. PubMed ID: 28082214
    [Abstract] [Full Text] [Related]

  • 8. Current Issues with Hysterectomy.
    Barker MA.
    Obstet Gynecol Clin North Am; 2016 Sep 20; 43(3):591-601. PubMed ID: 27521886
    [Abstract] [Full Text] [Related]

  • 9. Changes in Myomectomy Practice After the U.S. Food and Drug Administration Safety Communication on Power Morcellation.
    Stentz NC, Cooney LG, Sammel M, Shah DK.
    Obstet Gynecol; 2017 Jun 20; 129(6):1007-1013. PubMed ID: 28486366
    [Abstract] [Full Text] [Related]

  • 10. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
    Parker WH, Pritts EA, Olive DL.
    Clin Obstet Gynecol; 2016 Mar 20; 59(1):73-84. PubMed ID: 26670834
    [Abstract] [Full Text] [Related]

  • 11. Impact of the 2014 Food and Drug Administration Warnings Against Power Morcellation.
    Lum DA, Sokol ER, Berek JS, Schulkin J, Chen L, McElwain CA, Wright JD.
    J Minim Invasive Gynecol; 2016 Mar 20; 23(4):548-56. PubMed ID: 26827905
    [Abstract] [Full Text] [Related]

  • 12. Complication rate of uterine morcellation in laparoscopic supracervical hysterectomy: a retrospective cohort study.
    Smits RM, De Kruif JH, Van Heteren CF.
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr 20; 199():179-82. PubMed ID: 26943477
    [Abstract] [Full Text] [Related]

  • 13. Hysterectomies in Portugal (2000-2014): What has changed?
    Gante I, Medeiros-Borges C, Águas F.
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan 20; 208():97-102. PubMed ID: 27914240
    [Abstract] [Full Text] [Related]

  • 14. Hospital variation in responses to safety warnings about power morcellation in hysterectomy.
    Xu X, Desai VB, Wright JD, Lin H, Schwartz PE, Gross CP.
    Am J Obstet Gynecol; 2021 Jun 20; 224(6):589.e1-589.e13. PubMed ID: 33359176
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Morcellation Techniques at the Time of Laparoscopic Hysterectomy and Myomectomy.
    Meurs EAIM, Brito LG, Ajao MO, Goggins ER, Vitonis AF, Einarsson JI, Cohen SL.
    J Minim Invasive Gynecol; 2017 Jun 20; 24(5):843-849. PubMed ID: 28483536
    [Abstract] [Full Text] [Related]

  • 16. Laparoscopic myomectomy and morcellation: A review of techniques, outcomes, and practice guidelines.
    Glaser LM, Friedman J, Tsai S, Chaudhari A, Milad M.
    Best Pract Res Clin Obstet Gynaecol; 2018 Jan 20; 46():99-112. PubMed ID: 29078975
    [Abstract] [Full Text] [Related]

  • 17. Racial Disparities in Response to a US Food and Drug Administration Safety Communication Regarding the Use of Power Morcellation for the Treatment of Uterine Leiomyoma.
    Matsushita T, Sekizawa A, Jacobs LK.
    J Minim Invasive Gynecol; 2020 Jan 20; 27(1):178-185.e1. PubMed ID: 30936031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
    Perkins RB, Handal-Orefice R, Hanchate AD, Lin M, Paasche-Orlow MK.
    Womens Health Issues; 2016 Jan 20; 26(1):21-6. PubMed ID: 26701205
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.